Cryoport expects MVE New Prague production resumption Feb 14; $4-5M Q1 revenue impact

Cryoport, Inc.

Fire on Jan 25 at MVE Biological Solutions' New Prague facility halted production.
Production expected to resume week of Feb 14, 2022; full production ramp during Q1.
Revenue impact of $4-5 million limited to Q1 2022.
Insurance expected to cover majority of restoration costs and business interruption.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.